Search
Accendra Health Ord Shs
ACHAdd to Watchlist
0.248USD
-0.016-6.06%
Market hours 11/03, 14:47（ET）
19.09MMarket Cap
LossP/E TTM
Accendra Health Ord Shs (ACH) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts
Hold
0 Strong Buy
0 Buy
3 Hold
2 Sell
0 Strong Sell
Target Price
1.262USD+441.85%
ACH Analyst Recommendation Trends
In the current month, ACH has received 0 Buy Ratings, 3 Hold Ratings, and 2 Sell Ratings. ACH average Analyst price target in the last month is 1.263.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
1
1
1
1
1
0
0
0
0
0
0
0
0
3
3
4
2
2
2
2
2
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
5
5
6
5
5
5
5
5
ACH Analyst Rating for Peer Comparison
Updated: Nov 1, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Stryker Corp
SYK
11
13
7
0
0
31
Medtronic PLC
MDT
9
11
11
0
0
31
Dexcom Inc
DXCM
13
14
3
0
0
30
Abbott Laboratories
ABT
10
13
6
0
0
29
Guardant Health Inc
GH
12
14
2
0
0
28
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
6
20
0
0
28
Insulet Corp
PODD
7
7
12
0
0
26
Tandem Diabetes Care Inc
TNDM
5
8
11
0
0
24
Repligen Corp
RGEN
5
12
4
0
0
21
Financial Forecasting
Based on analysts' estimates, ACH EPS is projected to reach -0.010 in FY2026Q3, following reported EPS of -1.161 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.22
-0.10
-0.09
-0.01
0.22
Actual
-0.74
-0.08
-1.16
--
--
Surprise
-433.94%
+16.49%
-1214.79%
--
--
FAQs
What is Accendra Health Ord Shs's expected revenue for the next quarter?
Accendra Health Ord Shs's expected revenue is 617.38M.
What is Accendra Health Ord Shs's price target?
Analysts forecast that Accendra Health Ord Shs's price target is USD 1.26, with the highest forecast at USD 1.75 and the lowest forecast at USD 0.50.
How have Accendra Health Ord ShsACH's recent earnings per share performed?
The market expectation was USD -1.16, while Accendra Health Ord ShsACH's earnings per share (EPS) for the previous quarter was USD -0.08. EPS for the next quarter is expected at USD -0.01.
What is the analyst rating for Accendra Health Ord Shs?
Based on the ratings of Accendra Health Ord Shs's stock from 5 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.